Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewApilimod dimesylate is a potent and selective PIKfyve inhibitor (IC50 = 14 nM). Exhibits no significant activity at other lipid kinases and protein kinases, including PIP4K, PIP5K, mTOR, PI3K and PI4K. Inhibits cellular entry by SARS-CoV-2, MERS-CoV and MHV S pseudovirions. Apilimod dimesylate reduces the number of SARS-CoV-2-infected hiPSC-derived pneumocyte-like cells by 85% and inhibits SARS-CoV-2 replication in donor lung tissue. Also exhibits selective cytotoxicity in B-cell non-Hodgkin lymphoma compared with normal cells. Inhibits production of IL-12 and IL-23. In motor neurons derived from patients with amyotrophic lateral sclerosis (ALS) Apilimod dimesylate promotes exocytosis of neurotoxic proteins and in mouse ALS models, the compound reduces pathology and prolongs survival. Anti-inflammatory. Water-soluble.
Apilimod dimesylate is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. 了解 Tocris 化合物库的更多信息。
分子量 | 610.7 |
公式 | C23H26N6O2.2CH3SO3H |
储存 | Store at -20°C |
纯度 | ≥98% (HPLC) |
CAS Number | 870087-36-8 |
PubChem ID | 91885471 |
InChI Key | GAJWNIKZLYZYSY-OKUPSQOASA-N |
Smiles | C[S](O)(=O)=O.C[S](O)(=O)=O.CC1=CC=CC(\C=N\NC2=CC(=NC(OCCC3=CC=CC=N3)=N2)N2CCOCC2)=C1 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
溶剂 | 最高浓度 mg/mL | 最高浓度 mM | |
---|---|---|---|
溶解性 | |||
water | 61.07 | 100 | |
DMSO | 30.53 | 50 |
以下数据基于产品分子量 610.7。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
浓度/溶剂体积/质量 | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.64 mL | 8.19 mL | 16.37 mL |
5 mM | 0.33 mL | 1.64 mL | 3.27 mL |
10 mM | 0.16 mL | 0.82 mL | 1.64 mL |
50 mM | 0.03 mL | 0.16 mL | 0.33 mL |
参考文献是支持产品生物活性的出版物。
Wada et al (2007) Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. Blood 109 1156 PMID: 17053051
Cai et al (2013) PIKfyve, a class III PI-kinase, is the target of the small molecular IL12/23 inhibitor apilimod and a new player in toll-like receptor signaling. Chem.Biol. 20 912 PMID: 23890009
Riva et al (2020) Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 586 113 PMID: 32707573
Ou et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat.Commun. 11 1620 PMID: 32221306
Gayle et al (2017) Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. Blood 129 1768 PMID: 28104689
Hung et al (2023) PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. Cell PMID: 36754049
If you know of a relevant reference for Apilimod dimesylate, please let us know.
关键词: Apilimod dimesylate, Apilimod dimesylate supplier, Phosphatidylinositol, 3-phosphate, 5-kinase, PIKfyve, inhibitors, inhibits, potent, selective, SARS-COV-2, COVID-19, B, cell, non-hodgkin, lymphoma, NHL, interleukins, IL-23, IL-12, amyotrophic, lateral, sclerosis, ALS, induces, exocytosis, Other, Kinases, Endocytosis, Cytokines, Coronavirus, Exocytosis, 7283, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 Apilimod dimesylate 的部分引用包括:
Markku et al (2023) SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase. J Virol 97 e0014423 PMID: 37039676
您是否知道使用了 Tocris Apilimod dimesylate 的优秀论文? 请告知我们.
目前没有该产品的评论。 Be the first to review Apilimod dimesylate and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image